Most investors know that the stock market has delivered solid results over time, beating returns for bonds and many other popular assets. Less obvious is that most of the long-term gains have been ...

CRB-913 is an oral small-molecule inverse agonist targeting the CB1 receptor, a known pathway for weight loss. ・The study ...

Shares in biopharmaceutical company Arcus Biosciences ($RCUS) collapsed 17% in pre-market trading after it said it was ...

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is among the hidden multibagger stocks to invest in. It reported positive results from the registrational cohort of the EMBOLD study 4.

Bionomics Limited BNOX, a clinical-stage Australian biotechnology company, announced positive top-line results from its mid-stage study of BNC210 for the treatment of Post-Traumatic Stress Disorder ...

The research found that lawmakers who ascend to leadership outperform their peers by a whopping 47% annually after entering ...

Say that you and a friend were having a discussion about how the stock market works in 1996. Robert Shiller had just delivered his testimony to the Federal Reserve, in which he argued that investors ...

Athira Pharma, Inc ATHA recently announced that it has dosed the last patient in the phase II/III LIFT-AD study, which is evaluating its pipeline candidate, fosgonimeton for the treatment of ...

Spero Therapeutics (NASDAQ:SPRO) stock tumbled 20% post-market after the company announced it was cutting its workforce by 39% in the wake of a failed Phase 2 study for its drug SPR720. In a statement ...

The Motilal Oswal study reveals a cumulative wealth loss of ₹66,600 crore among the top 10 companies, with consumer sectors heavily impacted. Vodafone Idea and Rajesh Exports are notable wealth ...

Last week, the U.S. Supreme Court heard a case debating whether it's legal to restrict content moderation on social media platforms like Facebook, YouTube and X. Those companies should anticipate a ...